Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2017 (2017), Article ID 7982051, 6 pages
https://doi.org/10.1155/2017/7982051
Research Article

Suppression of Human Tenon Fibroblast Cell Proliferation by Lentivirus-Mediated VEGF Small Hairpin RNA

Department of Ophthalmology, Chaoyang Hospital, Capital Medical University, Beijing, China

Correspondence should be addressed to Zhongqiu Li

Received 24 March 2016; Revised 27 August 2016; Accepted 22 September 2016; Published 11 January 2017

Academic Editor: George M. Saleh

Copyright © 2017 Zhongqiu Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Daneshvar, “Anti-VEGF agents and glaucoma filtering surgery,” Journal of Ophthalmic and Vision Research, vol. 8, no. 2, pp. 182–186, 2013. View at Google Scholar · View at Scopus
  2. J. G. Crowston, “Long-term outcomes of trabeculectomy,” Clinical and Experimental Ophthalmology, vol. 36, no. 8, pp. 705–706, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Min, Z. L. Lukowski, M. A. Levine et al., “Prevention of ocular scarring post glaucoma filtration surgery using the inflammatory cell and platelet binding modulator saratin in a rabbit model,” PLoS ONE, vol. 7, no. 4, Article ID e35627, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. A. M. Palanca-Capistrano, J. Hall, L. B. Cantor, L. Morgan, J. Hoop, and D. WuDunn, “Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin c in primary trabeculectomy surgery,” Ophthalmology, vol. 116, no. 2, pp. 185–190, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. Z. Li, T. van Bergen, S. van de Veire et al., “Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery,” Investigative Ophthalmology and Visual Science, vol. 50, no. 11, pp. 5217–5225, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. H.-Y. Lopilly Park, J. H. Kim, M. D. Ahn, and C. K. Park, “Level of vascular endothelial growth factor in tenon tissue and results of glaucoma surgery,” Archives of Ophthalmology, vol. 130, no. 6, pp. 685–689, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Van Bergen, E. Vandewalle, S. Van de Veire et al., “The role of different VEGF isoforms in scar formation after glaucoma filtration surgery,” Experimental Eye Research, vol. 93, no. 5, pp. 689–699, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Vandewalle, L. A. Pinto, T. Van Bergen et al., “Intracameral bevacizumab as an adjunct to trabeculectomy: a 1-year prospective, randomised study,” British Journal of Ophthalmology, vol. 98, no. 1, pp. 73–78, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Suh and C. Kee, “The effect of bevacizumab on the outcome of trabeculectomy with 5-fluorouracil,” Journal of Ocular Pharmacology and Therapeutics, vol. 29, no. 7, pp. 646–651, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Ozgonul, T. Mumcuoglu, and A. Gunal, “The effect of bevacizumab on wound healing modulation in an experimental trabeculectomy model,” Current Eye Research, vol. 39, no. 5, pp. 451–459, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. B. E. Chua, D. Q. Nguyen, Q. Qin et al., “Bleb vascularity following post-trabeculectomy subconjunctival bevacizumab: a pilot study,” Clinical and Experimental Ophthalmology, vol. 40, no. 8, pp. 773–779, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Zarnowski and M. Tulidowicz-Bielak, “Topical bevacizumab is efficacious in the early bleb failure after trabeculectomy,” Acta Ophthalmologica, vol. 89, no. 7, pp. e605–e606, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. A. How, J. L. L. Chua, A. Charlton et al., “Combined treatment with bevacizumab and 5-fluorouracil attenuates the postoperative scarring response after experimental glaucoma filtration surgery,” Investigative Ophthalmology and Visual Science, vol. 51, no. 2, pp. 928–932, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Nilforushan, M. Yadgari, S. K. Kish, and N. Nassiri, “Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy,” American Journal of Ophthalmology, vol. 153, no. 2, pp. 352–357.e1, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Sengupta, R. Venkatesh, and R. D. Ravindran, “Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial,” Journal of Glaucoma, vol. 21, no. 7, pp. 450–459, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Georgalas, D. Papaconstantinou, I. Tservakis, C. Koutsandrea, and I. Ladas, “Severe hypotony and filtering bleb leak after intravitreal injection of ranibizumab,” Therapeutics and Clinical Risk Management, vol. 5, no. 1, pp. 17–19, 2009. View at Google Scholar · View at Scopus
  17. H. Xu, J. Liu, S. Xiong, Y.-Z. Le, and X. Xia, “Suppression of retinal neovascularization by lentivirus-mediated netrin-1 small hairpin RNA,” Ophthalmic Research, vol. 47, no. 3, pp. 163–169, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Yang, S. Chen, X. Luan et al., “MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells,” IUBMB Life, vol. 61, no. 11, pp. 1075–1082, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Choudhary and P. K. Wishart, “Non-penetrating glaucoma surgery augmented with mitomycin C or 5-fluorouracil in eyes at high risk of failure of filtration surgery: long-term results,” Clinical and Experimental Ophthalmology, vol. 35, no. 4, pp. 340–347, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. B. Sherwood, “A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis),” Transactions of the American Ophthalmological Society, vol. 104, pp. 478–492, 2006. View at Google Scholar · View at Scopus
  21. M. C. Gillies and T. Su, “Cytokines, fibrosis and the failure of glaucoma filtration surgery,” Australian and New Zealand Journal of Ophthalmology, vol. 19, no. 4, pp. 299–304, 1991. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Wu, S. Li, N. Wang, W. Liu, and W. Liu, “A comparative study of the safety and efficacy effect of 5-fluorouracil or mitomycin C mounted biological delivery membranes in a rabbit model of glaucoma filtration surgery,” Clinical Ophthalmology, vol. 7, pp. 655–662, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. J. C. Watson, O. A. Kadri, and M. J. Wilcox, “Effects of mitomycin C on glaucoma filtration capsules,” Biomedical Sciences Instrumentation, vol. 41, pp. 394–399, 2005. View at Google Scholar · View at Scopus
  24. P. T. Khaw, J. W. Doyle, M. B. Sherwood, M. F. Smith, and S. McGorray, “Effects of intraoperative 5-fluorouracil or mitomycin C on glaucoma filtration surgery in the rabbit,” Ophthalmology, vol. 100, no. 3, pp. 367–372, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Zachary, “VEGF signalling: integration and multi-tasking in endothelial cell biology,” Biochemical Society Transactions, vol. 31, no. 6, pp. 1171–1177, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Y. Choi, J. Choi, and Y.-D. Kim, “Subconjunctival bevacizumab as an adjunct to trabeculectomy in eyes with refractory glaucoma: a case series,” Korean Journal of Ophthalmology, vol. 24, no. 1, pp. 47–52, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Vasudev, M. P. Blair, J. Galasso, R. Kapur, and T. Vajaranant, “Intravitreal bevacizumab for neovascular glaucoma,” Journal of Ocular Pharmacology and Therapeutics, vol. 25, no. 5, pp. 453–458, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Grover, S. Gupta, R. Sharma, V. S. Brar, and K. V. Chalam, “Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma,” British Journal of Ophthalmology, vol. 93, no. 2, pp. 273–274, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. D. P. Smit and D. Meyer, “Intravitreal bevacizumab: an analysis of the evidence,” Journal of Clinical Ophthalmology, vol. 1, no. 3, pp. 273–284, 2007. View at Google Scholar
  30. J. Cao, L. Zhao, Y. Li et al., “A subretinal matrigel rat choroidal neovascularization (CNV) model and inhibition of CNV and associated Inflammation and fibrosis by VEGF Trap,” Investigative Ophthalmology & Visual Science, vol. 51, no. 11, pp. 6009–6017, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. R. A. Costa, R. Jorge, D. Calucci, J. A. Cardillo, L. A. S. Melo Jr., and I. U. Scott, “Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase 1 dose-escalation study,” Investigative Ophthalmology & Visual Science, vol. 47, no. 10, pp. 4569–4578, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Sugimoto, H. Mochizuki, H. Okumichi et al., “Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 248, no. 11, pp. 1601–1609, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. A. L. Moraczewski, R. K. Lee, P. F. Palmberg, P. J. Rosenfeld, and W. J. Feuer, “Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab,” British Journal of Ophthalmology, vol. 93, no. 5, pp. 589–593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Brouzas, C. Koutsandrea, M. Moschos, S. Papadimitriou, I. Ladas, and M. Apostolopoulos, “Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin) for AMD followed by controlateral sympathetic ophthalmia,” Clinical Ophthalmology, vol. 3, no. 1, pp. 457–459, 2009. View at Google Scholar · View at Scopus
  35. D. Kook, A. Wolf, A. S. Neubauer et al., “Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress,” Ophthalmologe, vol. 105, no. 2, pp. 158–164, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Huang, J. Cao, Q. Liu, Y. Zou, H. Li, and T. Yin, “MAPK/ERK signal pathway involved expression of COX-2 and VEGF by IL-1β induced in human endometriosis stromal cells in vitro,” International Journal of Clinical and Experimental Pathology, vol. 6, no. 10, pp. 2129–2136, 2013. View at Google Scholar · View at Scopus
  37. A. M. Doanes, D. D. Hegland, R. Sethi, I. Kovesdi, J. T. Bruder, and T. Finkel, “VEGF stimulates MAPK through a pathway that is unique for receptor tyrosine kinases,” Biochemical and Biophysical Research Communications, vol. 255, no. 2, pp. 545–548, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. H.-Y. L. Park, J. H. Kim, and C. K. Park, “VEGF induces TGF-β1 expression and myofibroblast transformation after glaucoma surgery,” American Journal of Pathology, vol. 182, no. 6, pp. 2147–2154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. M.-K. Yuan, Y. Tao, W.-Z. Yu, W. Kai, and Y.-R. Jiang, “Lentivirus-mediated RNA interference of vascular endothelial growth factor in monkey eyes with iris neovascularization,” Molecular Vision, vol. 16, pp. 1743–1753, 2010. View at Google Scholar · View at Scopus
  40. D. Peer and J. Lieberman, “Special delivery: targeted therapy with small RNAs,” Gene Therapy, vol. 18, no. 12, pp. 1127–1133, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Salmon, V. Kindler, O. Ducrey, B. Chapuis, R. H. Zubler, and D. Trono, “High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors,” Blood, vol. 96, no. 10, pp. 3392–3398, 2000. View at Google Scholar · View at Scopus
  42. Y. Guo, S. M. Srinivasula, A. Druilhe, T. Fernandes-Alnemri, and E. S. Alnemri, “Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria,” The Journal of Biological Chemistry, vol. 277, no. 16, pp. 13430–13437, 2002. View at Publisher · View at Google Scholar · View at Scopus